BLRX EPS Estimates
BioLineRx Ltd.
$2.21
+$0.23(+11.84%)
36
Overall
--
Value
30
Tech
42
Quality
Market Cap
$11.02M
Volume
3.06K
52W Range
$1.95 - $3.95
Target Price
$22.00
BLRX EPS estimates: the consensus estimate for BioLineRx Ltd.'s current fiscal year is -$1.57 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
BLRX EPS Estimates
- EPS estimate, current quarter
- $-0.38
- EPS estimate, next quarter
- $-0.40
- EPS estimate, current year
- $-1.57
- EPS estimate, next year
- $-1.26
- EPS growth, 3-year
- +92.53%
| Fiscal year | EPS |
|---|---|
| 2024 | $-0.01 |
| 2023 | $-0.06 |
| 2022 | $-0.45 |
| 2021 | $-24.00 |
| 2020 | $-72.00 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BLRX | $2.21 | +11.8% | 3.06K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |